These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3936213)

  • 1. Antithrombin III activity and concentration in diabetes mellitus.
    Patrassi GM; Picchinenna R; Vettor R; Cappellato G; Coccarielli D; Girolami A
    Thromb Haemost; 1985 Aug; 54(2):415-7. PubMed ID: 3936213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report.
    Ceriello A; Dello Russo P; Zuccotti C; Florio A; Nazzaro S; Pietrantuono C; Rosato GB
    Thromb Haemost; 1983 Oct; 50(3):633-4. PubMed ID: 6648886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activities and nonenzymatic glycosylation of plasma proteinase inhibitors in diabetes.
    Hall P; Tryon E; Nikolai TF; Roberts RC
    Clin Chim Acta; 1986 Oct; 160(1):55-62. PubMed ID: 2429788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily rapid blood glucose variations may condition antithrombin III biologic activity but not its plasma concentration in insulin-dependent diabetes. A possible role for labile non-enzymatic glycation.
    Ceriello A; Giugliano D; Quatraro A; Stante A; Consoli G; Dello Russo P; D'Onofrio F
    Diabete Metab; 1987 Feb; 13(1):16-9. PubMed ID: 3569629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylation.
    Ceriello A; Giugliano D; Dello Russo P; Tirelli A; Passariello N; Sgambato S
    Diabetes Care; 1986; 9(1):32-5. PubMed ID: 3948645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated haemoglobin and blood glucose levels in Libyan diabetic patients.
    Rao GM; Morghom LO; Abukhris AA; Mansori SS; Alphgih FA; Ragale LY
    Trop Geogr Med; 1986 Dec; 38(4):391-7. PubMed ID: 3810843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamic changes in the blood glucose, glycosylated hemoglobin and glycosylated serum protein values in patients with diabetes mellitus].
    Kalpazanova N; Dosheva I; Klechkova L
    Vutr Boles; 1987; 26(6):107-10. PubMed ID: 3439144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
    Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of insulin therapy on coagulation and platelet function in type II (non-insulin-dependent) diabetes mellitus.
    Small M; Douglas JT; Lowe GD; MacCuish AC; Forbes CD
    Haemostasis; 1986; 16(6):417-23. PubMed ID: 3108103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of glycosylated hemoglobin (HbA1) and fasting blood glucose in normal subjects and in patients with diabetes mellitus].
    Matsubara LS; Anselmo MA; de Paiva SA; Lima LC; Machado PE; Curi PR
    AMB Rev Assoc Med Bras; 1985; 31(11-12):227-31. PubMed ID: 3879703
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of poor glycaemic control on plasma levels and activity of protein C, protein S, and antithrombin III in type 2 diabetes mellitus.
    Addai-Mensah O; Annani-Akollor ME; Nsafoah FO; Fondjo LA; Owiredu EW; Danquah KO; Duneeh RV; Amponsah FA
    PLoS One; 2019; 14(9):e0223171. PubMed ID: 31560710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of glucose and glycosylated haemoglobin in Saudi diabetic patients.
    Ajabnoor MA; Laajam MA
    Trop Geogr Med; 1987 Jul; 39(3):276-80. PubMed ID: 3433344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressed antithrombin III biological activity in opiate addicts.
    Ceriello A; Dello Russo P; Curcio F; Tirelli A; Giugliano D
    J Clin Pathol; 1984 Sep; 37(9):1040-2. PubMed ID: 6470181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the effect of poorly controlled diabetes mellitus on erythrocyte life.
    Sayinalp S; Sözen T; Usman A; Dündar S
    J Diabetes Complications; 1995; 9(3):190-3. PubMed ID: 7548984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemoglobin A1 (HbA1) determination in Nigerian diabetics.
    Famuyiwa OO; Ogunmekan GO; Osotimehin BO
    Afr J Med Med Sci; 1983 Mar; 12(1):29-35. PubMed ID: 6314789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy.
    Asakawa H; Tokunaga K; Kawakami F
    J Diabetes Complications; 2000; 14(3):121-6. PubMed ID: 10989319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of blood glucose and haemoglobin A1 levels in diabetic subjects.
    Prendergast C; Smyth O; Murray F; Cunningham SK; McKenna TJ
    Ir J Med Sci; 1994 May; 163(5):233-5. PubMed ID: 8045728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet and coagulation factors in proliferative diabetic retinopathy.
    Borsey DQ; Prowse CV; Gray RS; Dawes J; James K; Elton RA; Clarke BF
    J Clin Pathol; 1984 Jun; 37(6):659-64. PubMed ID: 6202721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin preserves antithrombin III biological activity from hyperglycemia-induced alterations in insulin-dependent diabetics.
    Ceriello A; Giugliano D; Quatraro A; Stante A; Consoli G; Dello Russo P; D'Onofrio F
    Haemostasis; 1986; 16(6):458-64. PubMed ID: 3583099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antithrombin III in the Senegalese diabetic].
    Thiam D; Belem WC; Ndiaye MF; Diakhate L; Sow AM
    Dakar Med; 1990; 35(2):193-7. PubMed ID: 2135794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.